Company intelligence / Profile preview

Lacrivera

Cynthiana, Kentucky, United States

Ownership: Private
Development stage: Other

Overview

Lacrivera is an ophthalmology-focused dry eye product brand and division of Stephens Instruments that markets commercial products for punctal occlusion and related dry eye management. Its portfolio includes permanent and temporary punctal occluders such as FlexFit, VeraPlug, VeraPlug Flow, VeraC7, Vera90, and Vera180, along with diagnostic and ophthalmic instrument products. The company is focused on helping eye care professionals treat chronic dry eye and manage tear drainage through silicone and absorbable lacrimal plug products. Lacrivera operates in the healthcare sector as a commercial medical device business rather than a drug-development biotech company.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

USIOL (affiliate relationship mentioned by parent organization)

Beyond the preview

Go deeper on Lacrivera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lacrivera.

Explore the full profile